Yue Lei Shen
Chief Executive Officer at BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Net worth: 72 M $ as of 2024-04-29
Profile
Yue Lei Shen is the founder of Biocytogen Pharmaceuticals (Beijing) Co., Ltd., which was founded in 2009.
He currently holds the position of Chairman, President & Chief Executive Officer at Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
In addition, Dr. Shen is currently the President & Director at Biocytogen Boston Corp.
since 2018 and the General Manager & Executive Director at Eucure Beijing Biopharma Co Ltd since 2021.
Previously, he worked as a Manager & Member at Biocytogen LLC.
Dr. Shen completed his undergraduate degree at Wuhan University in 1992 and obtained his doctorate degree from the University of Massachusetts in 2004.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-29 | 64,235,700 ( 22.26% ) | 72 M $ | 2024-04-29 |
Yue Lei Shen active positions
Companies | Position | Start |
---|---|---|
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Chief Executive Officer | 2009-11-12 |
Biocytogen Boston Corp.
Biocytogen Boston Corp. BiotechnologyHealth Technology The American company was founded in 2018 by Yuelei Shen, and the CEO is Qingcong Lin. The private company operates in the biotechnology industry. | President | 2018-05-31 |
Eucure Beijing Biopharma Co Ltd | Chief Executive Officer | 2021-07-31 |
Former positions of Yue Lei Shen
Companies | Position | End |
---|---|---|
Biocytogen LLC | Corporate Officer/Principal | 2021-06-29 |
Training of Yue Lei Shen
Wuhan University | Undergraduate Degree |
University of Massachusetts | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Commercial Services |
Private companies | 3 |
---|---|
Biocytogen Boston Corp.
Biocytogen Boston Corp. BiotechnologyHealth Technology The American company was founded in 2018 by Yuelei Shen, and the CEO is Qingcong Lin. The private company operates in the biotechnology industry. | Health Technology |
Biocytogen LLC | |
Eucure Beijing Biopharma Co Ltd |
- Stock Market
- Insiders
- Yue Lei Shen